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Replacing the Draize eye test: 
Impedance spectroscopy as a 3R 
method to discriminate between  
all GHS categories for eye irritation
C. Lotz1, L. Kiesewetter1, F. F. Schmid2, J. Hansmann1,2, H. Walles1,2 & F. Groeber-Becker2
Highly invasive animal based test procedures for risk assessment such as the Draize eye test are under 
increasing criticism due to poor transferability for the human organism and animal-welfare concerns. 
However, besides all efforts, the Draize eye test is still not completely replaced by alternative animal-
free methods. To develop an in vitro test to identify all categories of eye irritation, we combined 
organotypic cornea models based on primary human cells with an electrical readout system that 
measures the impedance of the test models. First, we showed that employing a primary human 
cornea epithelial cell based model is advantageous in native marker expression to the primary human 
epidermal keratinocytes derived models. Secondly, by employing a non-destructive measuring system 
based on impedance spectroscopy, we could increase the sensitivity of the test system. Thereby, all 
globally harmonized systems categories of eye irritation could be identified by repeated measurements 
over a period of 7 days. Based on a novel prediction model we achieved an accuracy of 78% with a 
reproducibility of 88.9% to determine all three categories of eye irritation in one single test. This could 
pave the way according to the 3R principle to replace the Draize eye test.
The human eyesight is one of our most relied senses to perceive our environment. To ensure public health, all 
chemicals need to be evaluated for their potential to cause eye irritation. For this reason, an in vivo test system 
was developed by John Draize in 1944 to assess eye irritation1. In this Draize eye test, a test substance is applied 
in one eye of an albino rabbit and the effects, e.g. chemosis, conreal opacity, irititis, and conjunctival redness, are 
analyzed over a period of 21 days. Based on a scoring system, the tested chemical is then classified according to 
the United Nations globally harmonized systems (UN GHS) categories. Substances are labeled as (I) causing no 
irritation: no category, (II) serious eye damage: category 1 or (III) eye irritation: category 2. Hereby, category 2 can 
be further subcategorized as category 2A if an effect is reversible within 21 days or category 2B in case the caused 
effect persists not more than 7 days. Although the original test was improved following the 3Rs principle by the 
use of topical anesthetics and analgesics to reduce animal suffering, there are still ethical concerns and scientific 
limitations especially in regard to over-prediction and inter-laboratory variations2,3. These pitfalls and ethical 
issues drove a change in legislation to develop alternative test methods that do not include the use of test animals4.
For the endpoint of eye irritation, several ex vivo and in vitro test methods have been developed and incor-
porated into Organisation for Economic Co-operation and Development (OECD) guidelines5–9. The developed 
tests comprise a wide variety of models and analysis tools to identify category 1 and no category substances. Yet, 
no single test method can completely replace the Draize eye test and particularly category 2 substances causing 
reversible effects cannot be detected by the available test methods OECD TG 437,438,460,491 and 492. More 
recently, an in vitro procedure employing a reconstructed human cornea-like epithelium (RhCE) based on epi-
dermal keratinocytes was accepted as OECD test guideline 4929. The assay evaluates cytotoxicity of a test sub-
stance in a RhCE, measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-assay9. 
Nevertheless, the test procedure is limited to the discrimination between no category versus category 1 and 
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category 2 substances9. Thus, no single alternative test method is capable of identifying all UN GHS categories 
since the methods cannot distinguish between category 1 and category 2 substances.
The currently available models are either from non-human species or based on a different, non-corneal cell 
origin such as skin keratinocytes for the RhCE. The anatomical and molecular differences between species lead 
to false positive and false negative results in pharmaceutical and toxicological tests like the Draize eye test3. By 
using human-derived tissue models this critical pitfall can be avoided. However, no systematic study has been 
performed if and to what extend skin-derived cells influence the outcome of toxicological tests in comparison to 
cornea-derived cells. Therefore, a cornea epithelial model based on human corneal cells should be employed that 
mimics the histological morphology and the molecular network of native human cornea in comparison to the 
state of the art skin derived models.
Another drawback of the existing in vitro test system is the analysis via the destructive MTT-assay. As an 
endpoint-test, the enzymatic conversion of the yellow dye MTT into a blue MTT formazan salt by cells with an 
active metabolism render the model unusable for further testing10. Thus, no reversible effects can be detected. In 
addition, category 2 substances comprise subtle changes, which do not necessarily lead to cell death but might 
only decrease tissue integrity by the loss of cell-cell or cell-matrix connections11. Hence, the measurement of the 
epithelial barrier might be an additional parameter to refine current testing strategies. To investigate cellular 
barrier-functions the measurement of the transepithelial electrical resistance (TEER) was developed. However, 
the employed technical systems were mostly used for two-dimensional cell layers and are only of limited value in 
the assessment of multicellular barriers12. By using impedance spectroscopy capturing the complex alternating 
current resistance over a broad frequency spectrum, e.g. from 1 Hz to 100 kHz, one can identify small changes 
in the barrier also in three-dimensional tissue models caused at certain frequencies and enable more sensitive 
measurements to detect changes through mildly irritant substances.
This study aims to adapt an eye irritation test by adjusting the model and the analysis tool to identify all 
GHS categories. At first, a new model derived from human corneal epithelial cells was developed and com-
pared to an in-house developed cornea-like model based on skin keratinocytes and a standard reconstructed 
human epidermis (RHE) regarding epithelial marker localization and sensitivity to hazardous chemicals. To 
further refine the assessment of eye irritation, impedance spectroscopy was employed to monitor key changes 
non-destructively in the tissue integrity over 11 days. We hypothesize that, by the combination of an in vitro 
model with non-destructive impedance spectroscopy, a novel test procedure can be established to replace the 
animal based Draize eye test.
Results
Cornea-specific marker expression in the RCE model. Human primary cells are an important source 
to generate organotypic tissue models for preclinical research. They comprise the in vivo-like protein expression 
and metabolism to rebuild the native tissue’s anatomy and function13. To date, human epithelial cells from skin 
are employed to create tissue models for eye irritation according to the OECD test guideline 492. However, epi-
dermal cells from skin differ from the corneal epithelial cells of the eye in protein expression and metabolism14. 
To estimate whether a corneal cell source would be suitable for the assessment of chemicals for eye irritation, 
primary human epithelial cells from cornea and epithelial cells from skin were used to generate corneal tissue 
equivalents. The native cornea epithelium, in comparison to the epidermis of the skin, is a non-keratinized strat-
ified squamous epithelium. For comparison of the models’ anatomy, histological analysis of the reconstructed 
human cornea epithelium (RCE), modified reconstructed human epidermis (mRHE), reconstructed human epi-
dermis (RHE), native skin and native cornea was performed. The RCE and the mRHE show the same histological 
features as the native human cornea with 4 to 6 cell layers and little or no cornified layer. In contrast, the RHE 
features more cell layers and a keratinized layer comparable to the epidermis in vivo (Fig. 1). To further elucidate 
the molecular framework of the test models, an immunohistochemical staining of tissue-specific markers was 
performed. The ubiquitous epithelial marker cytokeratin 14 (K14) was expressed in the native tissues as well as in 
all of the three generated models. However, the cornea-specific markers cytokeratin 3 and 12 (K3/12) were only 
found in the native cornea and in the RCE. Cytokeratin 1 (K1), an epidermis marker, was visualized in the native 
skin, the RHE and the mRHE model but not in the RCE model. Moreover, the markers involucrin and loricin 
were analyzed to assess if a cornified layer was formed. The native cornea and the RCE showed a homogenous 
distribution of loricrin throughout all cell layers. On the contrary, locrin was limited to the stratum granulosum 
and the stratum corneum in the native epidermis, the RHE and the mRHE. Involucrin, as a substrate protein of 
transglutaminases, could be identified in the suprabasal layers of all studied epithelia (Fig. 1).
Highly sensitive impedance spectroscopy can be employed to measure tissue barrier func-
tion. To assess if the specific cell origins and marker expressions translate into different barrier functions, an 
ET50 assay was employed. Through the challenging of the models with the irritative substance Triton X-100 for 
defined periods, the time at which half of the cells in the model are viable can be measured as an indicator for the 
barrier function of the models. RHE with an ET50 value of 5.4 ± 0.9 hours is much less sensitive to Triton 100-X 
than the 1.1 ± 0.4 hours of the mRHE and 0.6 ± 0.9 hours of the RCE. In the ET50 assay, no significant discrimina-
tion could be found between the RCE and mRHE (Fig. 2A). As an additional method to determine the tissue bar-
rier, impedance spectroscopy was performed. By measuring the impedance over a frequency range from 1 Hz to 
100 kHz, specific courses of the amplitude of the impedance and the phase angle can be analyzed in the so called 
Bode plots. Curve shapes altered both with type of tissue and culture time and each tissue forms a distinct pattern 
mainly between 1 Hz and 1 kHz compared to the course of an empty insert membrane (dotted line in Fig. 2B). For 
the RHE, the amplitude showed a more stable plateau between 10 Hz and 1 kHz, whereas the amplitude declines 
faster for the mRHE and RCE models. Since differences between the models were only poorly visible at 12.5 Hz, 
the frequency at which the Millicell-ERS2 hand electrode determines the TEER value, we chose 1000 Hz as the 
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reference frequency for our study. In doing so, a new TEER value was defined by extracting the impedance ampli-
tude in Ω at 1000 Hz and by multiplying the culture area of the model (0.6 cm2), returning the TEER1000 Hz value 
in Ωcm2 used for analysis of all impedance data throughout the study.
Figure 1. Primary cell origin defines marker localization in tissue models. Histological characterization of 
cornea models. Hematoxylin and eosin (HE) staining of native human cornea (Cornea), reconstructed human 
corneal epithelium (RCE), modified reconstructed human epidermis (mRHE), reconstructed human epidermis 
(RHE) and native human skin (Skin). Tissue-specific proteins cytokeratin 3/12 (K3/12), cytokeratin 1 (K1), 
cytokeratin 14 (K14), loricrin (Loricrin) and involucrin (Involucrin) were visualized by immunofluorescence 
staining. Cell nuclei were labeled with DAPI. Dotted lines show the basal membrane and the scale bar indicates 
20 µm.
Figure 2. In vitro cornea models display a lower barrier function compared to reconstructed human epidermis. 
(A) ET50 assay to evaluate barrier properties of reconstructed human epidermis (RHE), reconstructed 
human corneal epithelium (RCE), and modified reconstructed human epidermis (mRHE) (n = 3; mean 
value ± SD). (B) Amplitude of the impedance of RHE, RCE, and mRHE in comparison to an empty insert. (C) 
Transepithelial electrical resistance measured at 1000 Hz and multiplied by the culture area of RHE, RCE, and 
mRHE (n = 30; mean value ± SD; p < 0.05).
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Measuring the TEER1000 Hz resulted in significant differences between the RHE and the mRHE but also 
between the mRHE and the RCE (Fig. 2C), which could not be detected by the ET50 assay (Fig. 2A). The RHE 
thereby had the highest TEER1000 Hz of 9268 ± 1929 Ωcm2 followed by the mRHE with 4422 ± 1366 Ωcm2 and the 
RCE with the lowest TEER1000 Hz of 232 ± 142 Ωcm2, showing a similar trend as in the results of the ET50 assay. 
(Figure 2C).
RCE demonstrates best eye irritation prediction in MTT-assay. In the next step, the models and the 
TEER measurements were implemented in an eye irritation testing protocol based on the OECD TG 492. Therefore, 
the models were measured before and after the application of the nine test chemicals, three of each GHS category 
(Table 1 and Fig. 3). To challenge the new protocol, toluene and citrate were selected on the basis that they cannot be 
predicted indisputably with the state-of-the-art tests. Phosphate-buffered saline was employed as negative control 
and 5% sodium dodecyl sulfate as positive control. As defined in the published test protocol, 60% viability was used 
as a cut-off value to distinguish irritative and non-irritative substances9. Technical duplicates were employed, similar 
as in the validation study of the accepted test method implemented in the TG 492. On top, three independent test 
runs with tissues generated from cells of different donors were performed to ensure robustness.
At first, the performance of the models was tested using the standard MTT-analysis. RHE had a higher viabil-
ity compared to the mRHE and the RCE, when category 1 and category 2 substances such as sodium dodecyl sul-
fate and acetone were applied. The mRHE led to reproducible test results in the three test runs and the technical 
duplicates with one exception in case of ethanol. In comparison to the RHE, the mRHE demonstrated a stronger 
decline of viable tissue for category 1 substances. The RCE was the only model that showed significant reduction 
of viability for category 2 substances (Fig. 3A,B). While the RCE had the same outcome for the technical repli-
cates, one donor-specific outlier was found in the test results for acetone and ethanol, though. The unharmonized 
test substances toluene and citrate reduced the viability of all models below the threshold of 60% (Fig. 3). Taken 
together, all three models achieved the same specificity of 66.7% in identification of irritants. However, the RHE 
showed the lowest sensitivity of 50% and lowest accuracy of 55.7%. The mRHE prediction was better with a 
sensitivity and an accuracy of 66.7%. The best results were achieved with the RCE with 100% sensitivity and 88% 
accuracy employing the MTT-based test method derived from the OECD TG 492 protocol.
To evaluate the capacity of the models to distinguish between the different categories, statistical analysis was 
performed taking the combined results from all test substances in each category (Fig. 3B). No significant differ-
ence between the groups could be found for the RHE. Meanwhile, the mRHE and the RCE were able to distin-
guish between no category and category 1. Additionally, the RCE showed the biggest differences between irritants 
and non-irritants in the analysis.
TEER measurements improve sensitivity in RHE and mRHE. TEER measurements enable the detec-
tion of differences that could not be observed via the MTT-assay (Fig. 2C). To allow comparability between the 
different models, the TEER1000 Hz was normalized to the negative control. Glycerol showed a decrease in the tissue 
integrity, whereas toluene induced only a moderate drop in the MTT data. Furthermore, the impedances of the 
category 1 chemicals imdiazole, benzalkonium chloride and sodium dodecyl sulfate decreased below 20% of the 
intact tissue in the RHE and mRHE. The values of category 2 chemicals acetone and ethanol fell between 20% and 
50%. Citrate resulted in similar shifts as the chemicals of category 1. The RCE values were overall high and did 
only show minor changes between the different chemicals of the categories (Fig. 4A).
To address the question whether the TEER1000 Hz can discriminate between the respective GHS categories, the 
results from each category were combined. By using the TEER measurements, the predictive capability increased 
for RHE and mRHE. The RHE was able to identify differences between no category and category 1 and the mRHE 
between no category and category 1 as well as among no category and category 2. However, the predictive capa-
bility did not increase for the RCE-based test protocol (Fig. 4B). Although there are clear differences between 
irriating and no non-irritating substances, it should be noted that a clear differentiation between category 1 and 2 
is not possible. Thus, in the second step we added repeated TEER measurements over 11 days to gain also infor-
mation concerning the persistence of irritating effect.
Repeated TEER measurements allow for distinction between the GHS categories. To assess 
whether an effect is reversible, we measured the TEER1000 Hz before the application of the test substance, directly 
after the application and on day 1, 3, 7 and 11. Due to the high predictive capability in the TEER1000Hz-based 
test protocol and less donor deviation compared to the RCE, the mRHE was chosen as the best suited model to 
perform repeated TEER measurements. Of the no-category substances, glycerol showed an initial decrease of 
TEER1000 Hz value between 29% and 66%. Subsequently, the impedance recovered over time and reached over 
100% at day 11. The TEER1000 Hz of potassium tetrafluorobate stayed at around 100% compared to the negative 
control over the whole time period. For toluene as a non-harmonized substance, values decreased only slightly 
directly after the application. However, the effect was persistent and led to a continuous decrease over the 11 days 
resulting in TEER1000 Hz values below 50%. Category 1 substances, in contrast, decreased the TEER1000 Hz-value 
below 6% of the initial level showing no recovery during the 11 days. The TEER1000 Hz of mildly irritating category 
2 substances with the exception of citrate dropped below 50% after the application and recovered to levels slightly 
above 50% during 11 days (Fig. 5A). Interestingly, the impedance of citrate showed a comparable course to cate-
gory 1 substances and decreased to less than 8% with no signs of recovery.
To verify that the repeated measurements allow for distinguishing between the different categories, statistical 
analysis was performed at each measurement point (Fig. 5B). Before the application of the test substances, no 
significant differences can be found. However, after application of the chemicals the pairs no category versus 
category 1 and no category versus category 2 can be differentiated as shown before. Following a post-incubation 
period of 1 and 3 days, all eye irritation categories show significant different TEER1000 Hz values. After day 7, 
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models challenged with no category and category 2 test substances reached similar tissue integrity and did not 
differ significantly, while still being significantly different to category 1 (Fig. 5B).
Discussion
Tissue engineering was developed as a technology to replace organ defects. However, since functional tissue 
equivalents are created, the same technology is applicable for the creation of organotypic tissue models for toxic-
ity testing or pre-clinical research. Using these models, novel standardized test methods were developed that in 
some cases reached sufficient predictivity to become part of internationally valid OECD guidelines6,8,9,15. Despite 
Figure 3. MTT-based eye irritation test cannot distinguish between all eye irritation categories. Eye irritation 
test with reconstructed human epidermis (RHE), reconstructed human corneal epithelium (RCE), and modified 
reconstructed human epidermis (mRHE) according to OECD TG 492. (A) The viability was normalized to the 
negative control. Three different test substances of each GHS category for eye irritation were applied (three test 
runs with duplicates). (B) To assess the ability of the different models to distinguish between the eye irritation 
categories, test substances were grouped to the respective GHS category for eye irritation. Shown are mean 
values and standard deviation of the substances from each category. The viability was normalized to the negative 
control (n = 9; mean value ± SD; p < 0.05).
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these advances, some toxicological endpoints still require additional animal-based test methods for a meaningful 
prediction. Although the recent advances in the development of tissue engineered corneal models led to the new 
OECD TG 492 that can discriminate between irritants and non-irritants, until today no stand-alone test proce-
dure has been developed to fully replace the Draize eye test. In this systematic study we could show that the cor-
nea derived models, while having a native molecular pattern, demonstrate no significant improvement over the 
skin based models for the prediction of eye irritation. However, through the use of the TEER1000Hz in combination 
with the mRHE we could distinguish between all categories of eye irritation by repeated measurements over 7 
days of the treated models.
Figure 4. TEER1000 Hz improves sensitivity of eye irritation testing. The impedance of reconstructed human 
epidermis (RHE), reconstructed human corneal epithelium (RCE), and modified reconstructed human 
epidermis (mRHE) was measured. (A) The TEER1000 Hz was normalized to the negative control. Three different 
test substances of each GHS category for eye irritation were applied (three test runs with duplicates). (B) To 
assess the ability of the different models to distinguish between the eye irritation categories, test substances were 
grouped to the respective GHS category for eye irritation. Shown are mean values and standard deviation of the 
substances from each category. The TEER1000 Hz was normalized to the negative control (n = 9; mean value ± SD; 
p < 0.05).
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To replace the Draize eye test we hypothesized that a corneal model in combination with a non-destructive 
measurement should allow to distinguish all GHS categories of eye irritation in vitro. Hence, in this study we 
generated cornea epithelium models based on either skin derived keratinocytes as a reference to the state of the 
art models or primary cornea epithelial cells and compared these models in regard of morphology and the local-
ization of cornea and skin-specific cellular markers. One of the essential differences between cornea and the skin 
Figure 5. Repeated TEER1000 Hz measurements allows to distinguish between all eye irritation categories. 
Ability to distinguish eye irritation categories by repeated TEER1000 Hz measurements. (A) Eye irritation test with 
repeated TEER1000 Hz measurements normalized to the control of the modified reconstructed human epidermis 
(mRHE) during a time period of 11 days after application of the chemicals (n = 3;. mean value). (B) To assess 
the ability of the different models to distinguish between the eye irritation categories, test substances were 
grouped to the respective GHS category for eye irritation. Shown are mean values and standard deviation of the 
substances from each category. (n = 9; mean value ± SD; p < 0.05). (B) (n = 9; p < 0.05).
www.nature.com/scientificreports/
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is the cornification of the epithelium. The cornified layers of the epidermis function as a tight barrier formed by 
dead tissue to protect us from physical, chemical, and biological hazards. The cornea on the other hand needs to 
be transparent to allow light to reach sensory cells in the retina and thus does not comprise keratinized layers. 
Without this strong physical barrier, the cornea is more vulnerable. So to mimic the situation, a model system 
should not feature a cornified layer in order to decrease the sensitivity14.
The cornea epithelial cells show no cornification in the RCE model in comparison to the epidermal keratino-
cytes from the RHE. Yet, keratinocytes from the epidermis and cornea epithelium are closely related by the origin 
from the ectoderm and it could be shown that cornea keratinocytes transdifferentiate to epidermal keratinocytes 
and vice versa14,16. Therefore, both cell origins seem suitable for generating models for eye irritation testing. This 
close relationship between both cell types was recently used to generate the EpiOcular® cornea epithelial model 
that was successfully validated9. In our approach, a similar anatomy as the native cornea was achieved by reducing 
the culture time of RHE to eleven days. During this time, we could show that the model has not formed cornified 
layers and has a significantly reduced barrier. Nevertheless, the anatomical differences between skin and cornea 
are caused by a significantly different genetic expression profile17. Moreover, involucrin as a substrate for trans-
glutaminases is expressed in the upper layers and loricrin in the stratum corneum18. Although the cornea has a 
comparable pattern for keratin 14, differentiated cornea epithelium comprises a different network of keratin 3 and 
12 instead of keratin 1 in the epidermis19. Furthermore, loricrin is found throughout the cornea epithelium and, 
thus, indicating a different function in cornea as described in epidermis20. The basic anatomy between the mRHE 
and the RCE was comparable in our models, however the marker pattern of skin derived cells still mimicked the 
one of skin. Equally cornea derived cells showed the pattern found in native human cornea and cornea-specific 
markers such as keratin 3 and 12 were visible. Also, the distribution of the cornified envelope protein loricrin 
demonstrated that the cornification is different to the mRHE and RHE (Fig. 1).
To test the hypothesis that the anatomic differences translate to a different tissue barrier, an ET50 assay 
was performed. As expected, the cornified RHE can withstand a hazardous substance much longer than the 
non-cornified mRHE and RCE, since the Triton X-100 can directly interact with the living cells and does not 
have to pass the physical barrier of the stratum corneum. For the RCE and the mRHE, no significant difference 
of the ET50 value in the amount of metabolically active cells can be observed, implying a similar barrier of both 
models. However, employing impedance spectroscopy, a clear difference can be seen. Impedance spectroscopy 
measures the complex alternating current resistance over a defined frequency spectrum and was employed as a 
highly sensitive method to assess the influence of different substances on the barrier function of tissue models12. 
An integral part of the previous published method was the mathematical model to derive quantitative data from 
the impedance spectra. Therefore, a simulation was run based on an equivalent circuit to gain deeper insight into 
the process involved given the biological reaction. The analysis revealed that the thickness of the model correlates 
with the capacitance. However, no benefit could be detected in the identification of hazardous substances com-
pared to the here defined TEER1000 Hz (Supplementary Figs 2–4). Although the model allows the precise determi-
nation of electrical parameters such as the capacitance or the ohmic resistance, skilled personal and specialized 
programs are needed to run the simulation. Since a toxicological test should be based on readably accessible 
technologies that allow a board dissemination of the test method, we developed a novel readout parameter based 
on the impedance at one defined frequency. The best predictive capability and robustness could be achieved at 
1000 Hz, we used the TEER value at this frequency as the readout parameter. The TEER1000Hz was chosen delib-
erately to ensure an easy use of the test method around the globe, without the need of a complex mathematical 
fit. Standard measuring systems such as the EVOM system that measures at 12.5 Hz were developed to measure 
the electrical properties of a single cell layer. Our data shows that at this frequency the predictive capability for 
three-dimensional tissues is limited as the difference between the unseeded membrane and a mature model is 
only 19.9 dB (9.9 Ω), whereas for the TEER at 1000 Hz a difference of 36.6 dB (67.7 Ω) can be achieved. Using this 
method, the RCE model reached a TEER1000 Hz value of only 231 Ωcm2 that is significantly lower than the values 
for the mRHE with 4422 Ωcm2 and the RHE with 9268 Ωcm2.
Thus, our data suggests that there is a considerable difference between barrier function and marker expression 
pattern between an in vitro model created from skin or cornea cells. However, to the best of our knowledge there 
is a lack of data if these differences translate to different predictive capacities in an eye irritation assay. Thus, we 
used all models and compared the performance in an eye irritation assay based on OECD test guideline 492. The 
test substances were selected from all GHS categories to show feasibility of the test method. Toluene and citric 
acid were added as unharmonized test substances to provide more insight into their classification and to pose a 
challenge for the newly developed test method. Since the intention of this study was to test the feasibility of the 
new impedance-based assay, we limited the number of test substances to nine but suggest to validate the method 
to evaluate the newly 80 reference chemicals published by the consortium for in vitro eye irritation testing21.
In the MTT-based eye irritation test, the RCE came closest to distinguish between irritant and non-irritants. 
Significant changes could be observed between no category against category 1 and a tendency for category 2. This 
makes the RCE a suitable model for a MTT-based test procedure comparable to the OECD TG 4929. Yet, due 
to donor variances there is still potential for improvement in the selection of donor material. The mRHE could 
identify category 1 against no category, which is insufficient for safety assessment, detecting non-irritating chem-
icals. Nevertheless, the OECD TG 492 proves that an epidermal keratinocyte-derived model can be employed. 
This difference between our model and the published procedure may be because of the smaller selection of test 
substances in this work. However, the focus of the study was on non-harmonized substances such as citric acid 
and toluene to get new insights in their categorization but complicating the interpretation22. The RHE was not 
able to distinguish between any categories in a MTT analysis. This supports the hypothesis that the cell origin, 
while leading to a different marker expression in the model, does not play a deciding role in the classification of 
substances for eye irritation. This might be different in regard to drug transport studies or metabolism of drugs.
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The current in vitro eye irritation assays basically follow the experimental approach developed for the identi-
fication of skin irritants and skin corrosives. After the application of a test substance the model is measured via a 
MTT assay and categorized depending on viability normalized to the negative control. However, the classification 
of eye irritants also require determination of how persistent a reaction is or, in other words, if a caused effect is 
reversible or not. In the Draize eye test the discrimination between category 2 reversible and category 1 irrevers-
ible effects is done by monitoring the rabbit’s eye over a period of 21 days. In case the damage is reversible on day 
7 or day 21, the test substance is categorized as 2B or 2A. To test for reversible effects, standard destructive colori-
metric assays are not best suited since they lack the possibility to measure the same tissue repeatedly over different 
time periods and do only take into account effects within the metabolically highly active basal cell layers. As a 
complementary method impedance spectroscopy could refine test results with the possibility to non-destructively 
assess also mild effects in the upper cell layers. For instance, it can detect the loss of cell-cell interactions, thereby 
identifying more sensitive changes caused by the tested chemical. To test this hypothesis, we determined the 
TEER1000 Hz value before substance application, and right before MTT-measurements and normalized these values 
to the negative control.
The TEER measurements demonstrated that the electrical analysis allows the detection of smaller differences 
between the models in comparison to the MTT-based ET50 barrier assay. First, the TEER1000 Hz of category 2 sub-
stances ethanol and acetone dropped below 45% in the mRHE and RHE, showing an irritative effect in compari-
son to the MTT-based evaluation. Second, the category 1 substances dropped below 5% and thus even lower than 
the category 2 substances. Therefore, the ability to distinguish between the categories with the mRHE and the 
RHE models was improved. The differences for the RCE between the categories were smaller and more heteroge-
neous. The barrier value was small and the differences were possibly surpassed by donor variances. Nonetheless, 
this demonstrates the additional value of employing not only a MTT assay but implementing also a more sensitive 
impedance measurement to improve the test procedure (Fig. 4).
To evaluate all GHS categories for eye irritation, it is important to understand the drivers of eye irritation in 
each category. Category 2 has to be evaluated by monitoring the rabbit’s eye over 21 days, to determine the revers-
ibility of an effect. In addition, the majority of category 1 chemicals (65%) were classified solely on persistence 
effects, meaning that the quality of the injury was second to the persistence3. This highlights the importance of 
an analysis which is able to measure non-destructively repeated measurements. Because the TEER measurement 
allows for repeated measurements of the same model, similar to the observation of the eye in the Draize eye test, 
it is possible to evaluate reversible effects over time (Fig. 5). Hence, we developed a test procedure, in which we 
measured the TEER1000 Hz not only before and after test substance application but also subsequently over a post 
incubation time of 11 day. Since the mRHE model showed the most promising results in the previous test, we 
employed only this model for the impedance based recovery assay. For each category clear progression patterns 
of reversible or irreversible effects can be identified by the repeated TEER measurements. Substances that do not 
need categorization stay around 100% of the control over 11 days, showing no effect. A downward trend after the 
application, still above 60%, was observable probably caused by the test procedures including multiple washing 
steps that were already found to influence the barrier. The TEER1000 Hz of category 1 substances decreased the 
barrier to less than 6% after the substance application. Subsequently, the challenged tissues did not show any sign 
of recovery and the barrier stayed below 6% and did not increase anymore. Category 2 substances also show a 
clear decrease after application below 60%, identifying an irritative effect, but in contrast to category 1 substances 
the TEER1000 Hz increases again over time above 50% showing a regeneration of the barrier and the reversibility 
of the effect.
Using this data, we developed a prediction model that uses two time points for the categorization into the 
three GHS categories (Fig. 6). Directly after the application a 60% cut-off value is used to discriminate not cate-
gorized substances versus category 2 and category 1 substances. On day 7 an impedance of 50% is used to distin-
guish category 2 and category 1 substances. Substances that allow a recovery over 50% are classified as category 2 
substances. Effects that persist over more than 7 days indicate strong eye damage and thus the categorization in 
category 1. In case a substance leads to an impedance value over 60% directly after the application but to a value 
below 60% on day 7, a persistent effect over time can be assumed that leads to the categorization in category 1.
Employing this prediction model the performed test scores 78% accuracy, making it the first in vitro test to 
distinguish all GHS categories for eye irritation in one test (Table 2). Moreover, we could achieve a reproducibility 
between the test runs of 88.9% with glycerol being the only exception where we classified the substance as cate-
gory 2 in one run and no-category in two runs. Although toluene and citrate are partly classified as no category 
substances, this test suggests a much stronger irritative capacity of both substances. This finding is also supported 
by several studies that show strong irritative effects of toluene and citrate23–25. In addition, toluene is categorized 
as a skin irritant by the European Chemcials Agency. Taking this into consideration, the test method presented 
here yields an accuracy of 100%.
Finally, this methods holds the potential to subcategorize substances as category 2A and 2B by identifying 
more or a faster regeneration between substances of category 2A and 2B. However, if this is necessary is open 
for discussion since the regulatory bodies have different opinions on the matter. The European Union for exam-
ple did not include the subcategories. TEER measurements at 12.5 Hz have shown to be a profound method to 
evaluate 118 chemicals for eye irritation23. In this study, however only three minutes after the application were 
measured not allowing for further evaluation of the reversibility of effects. In addition, we could show that the 
TEER measurements at 1000 Hz are more sensitive to evaluate corneal epithelial models. To our knowledge only 
the porcine corneal ocular reversibility assay can distinguish between the GHS categories for eye irritation in one 
test26. However, the test method uses porcine eyes, which could lead again to species differences and still relies on 
animal material. In addition, the procine corneal ocular reversibility assay is not a validated method and has not 
been adopted into the OECD guidelines.
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The systematic analysis of in vitro models derived from corneal and epidermal epithelial cells identifies 
anatomical and molecular differences. Nonetheless, the RCE and the mRHE translate into appropriate models 
for the identification of hazardous chemicals for eye irritation. Furthermore, the implementation of impedance 
spectroscopy led to a more precise analysis tool compared to a MTT-based test. Finally, by employing this 
non-destructive measurement tool repeated measurements allow for the evaluation of recovery or persistence 
of effects. This enables for the first time the identification of all three GHS categories for eye irritation in one 
single test. The next step could include a larger amount of test substances to identify possible limitations of the 
TEER measurements and conclude in the validation of an improved OECD TG 492 to make the animal-based 
Draize eye test obsolete.
Figure 6. TEER1000 Hz prediction model for the classification of substances according to the GHS categories for 
eye irritation.
Test substance After Day 7 Prediction GHS
Glycerol >60% >50% No cat. No cat.
Potassium tetrafluorobate >60% >50% No cat. No cat.
Toluene >60% <50% Cat. 1 No cat.
Acetone <60% >50% Cat. 2 Cat. 2
Ethanol <60% >50% Cat. 2 Cat. 2
Citrate <60% <50% Cat. 1 Cat. 2
Imidazole <60% <50% Cat. 1 Cat. 1
Benzalkonium chloride <60% <50% Cat. 1 Cat. 1
Sodium dodecyl sulfate <60% <50% Cat. 1 Cat. 1
Table 2. Categorization of tested substances according to the TEER1000 Hz prediction model.
Test substance CAS-Number UN GHS category
Glycerol 56-81-5 No category
Potassium tetrafluorobate 14075-53-7 No category
Toluene 108-88-3 No category
Acetone 67-64-1 Category 2
Ethanol 64-17-5 Category 2
Citrate 77-92-9 Category 2
Imidazole 288-32-4 Category 1
10% Benzalkonium chloride 8001-54-5 Category 1
15% Sodium dodecyl sulfate 151-21-3 Category 1
Table 1. List of test substances used in the eye irritation test. For all substances the respective number of the 
Chemical Abstracts Service (CAS-number) and the classification according to UN GHS are provided. For citrate 
and toluene, the category was chosen based on the majority of reports submitted to the European Chemicals 
Agency since no harmonized classification is available.
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Methods
Human material. All experiments were conducted in compliance with the rules for investigation on human 
subjects, as defined in the Declaration of Helsinki. Informed consent was obtained from all subjects prior to the 
study. Human corneal cells were isolated from spare limbal rings and from corneas that failed the quality criteria for 
clinical use in accordance and with the approval of the local ethics committee (Ethik-Kommission der Universität 
Würzburg, approval number 182/10) and the informed consent of the patients for the study participation. Corneal 
biopsies were provided by the eye clinic of the Universitätsklinikum Würzburg (Würzburg, Germany). Human 
epidermal keratinocytes were isolated from foreskin biopsies of 2–5 year old donors in accordance and with the 
approval of the local ethics committee (Ethik-Kommission der Universität Würzburg, approval number 182/10) and 
the informed consent of the patients or their guardians for the study participation. Foreskin biopsies were provided 
by the Klinikum Frankfurt Höchst (Frankfurt, Germany). No tissues were procured from prisoners.
Cell isolation and culture. Human epidermal keratinocytes were isolated from foreskin using a 
well-established protocol described previously27. In brief, biopsies were washed, minced and digested with dis-
pase [2 U/ml] (Life technologies, Germany) for 18 hours at 4 °C to dissociate the epidermis from the dermis. 
Thereafter, the epidermis was trypsinized (Thermo Fisher Scientific, Waltham, MA USA) to generate single cell 
suspensions. The epidermal keratinocytes were cultured in EpiLife® medium containing human keratinocyte 
growth supplement (Both from Thermo Fisher Scientific, Waltham, MA USA)).
Corneal tissues were transferred and washed in a petri dish with phosphate-buffered saline. Subsequently, the 
cornea was cut into horizontal stripes of about 2–3 mm and put in a petri dish with dispase [2 U/ml] (Thermo 
Fisher Scientific, Waltham, MA USA)) for 18 hours at 4 °C. The epithelium was stripped off the central cornea 
to the limbus with forceps and collected in a new petri dish with fresh phosphate-buffered saline. The epithelial 
sheets were centrifuged and reduced to small pieces by pipetting for cell seeding. The corneal epithelium was 
cultured in corneal epithelial cell medium (LGC Standards, Wesel, Germany).
Tissue models. The RHE was generated as previously described28. Briefly, human epidermal keratino-
cytes were seeded on cell culture inserts with a polycarbonate membrane (0.4 µm pore size, Merck, Darmstadt, 
Germany) at a cell density of 5 × 105 cells/cm2 in 150 μl EpiLife® supplemented with human keratinocyte growth 
supplement and 1.5 mM CaCl2 (Sigma-Aldrich, Munich, Germany). Medium was changed after 24 hours to 
EpiLife® air-liquid-interface medium, additionally containing 73 μg/ml L-ascorbic acid 2-phosphate and 10 ng/
ml keratinocyte growth factor (both Sigma-Aldrich, Munich, Germany). The RHE models were cultured for 20 
days. In order to generate the mRHE, the culture period was reduced to 11 days. The RCE was generated from 
human corneal epithelial cells. The cells were seeded as described above with a cell density of 2.5 × 105 cells/cm2 
and cultured for 11 days.
Histology. Native tissue and tissue models were fixed in Roti®-Histofix (Carl Roth, Karlsruhe, Germany) for 
2 hours before generating histological cross-sections of 4 µm thickness. As an overview of general histological fea-
tures, tissue slides were stained with hematoxylin and eosin (H&E; Morphisto, Frankfurt am Main, Germany). For 
immunohistochemical staining tissue slides were rehydrated and blocked with 5% donkey serum for 30 minutes. 
Subsequently, the primary antibodies cytokeratin 3/12 (1:100 dilution; Bioss, MA USA), cytokeratin 1 (1:1000 dilu-
tion; Abcam, Cambridge, United Kingdom), cytokeratin 14 (1:100 dilution; Sigma-Aldrich, Munich, Germany), 
involucrin (1:200 dilution; Thermo Scientific Fisher, MA USA) and loricrin (1:500 dilution; Abcam, Cambridge, 
United Kingdom) were added and incubated at 4 °C overnight. After washing, the slides were exposed to the match-
ing secondary antibodies Alexa Fluor® 555 donkey anti-mouse or Alexa Fluor® 555 donkey anti-rabbit (1:400 dilu-
tion; Thermo Fisher Scientific, Waltham, MA USA) for 30 minutes at room temperature. The sections were covered 
with Fluoromount-G DAPI (Thermo Fisher Scientific, Waltham, MA USA) to visualize the cell nuclei.
Epithelial barrier assay. The epithelial barrier was determined by the exposure time required to reduce 
cell viability by 50% (ET50) as described previously29. Briefly, the tissue models were topically exposed to 25 µl of 
1% (w/v) Triton X-100 (Sigma-Aldrich, Munich, Germany) at 37 °C for 0.5, 1.5, 3.0, 4.5 and 6 hours to determine 
the ET50 value indicative for the respective barrier. To equally cover the model, the Triton X-100 was frothed 
up by pipetting. Untreated models served as a negative control. After incubation the models were washed in a 
beaker with 150 ml phosphate-buffered saline. The models were put into a 24-well plate with 300 µl of 1 mg/ml 
MTT-solution and incubated for 3 hours at standard culture conditions. To solubilize the blue formazan, the 
inserts were submersed in 2 ml isopropanol at 4 °C overnight. Finally, the insert membranes were punched and 
200 µl of each sample was measured in duplicates in a 96-well plate with a spectrometer (Infinite M200 Pro, Tecan, 
Männedorf, Switzerland) at a wavelength of 570 nm using isopropanol as blank.
Impedance spectroscopy measurement. The impedance spectroscopy measurement was performed 
as previously described30. In brief, a sinusoidal electrical current I(f) [A] was generated and the potential differ-
ence U(f) [V] was measured by an impedance spectrometer LCR HiTESTER 3522-50 (HIOKI E.E. Corporation, 
Nagano, Japan) to record the impedance spectra Z(f) of biological samples. A custom-made user interface, 
programmed in LabVIEW (National Instruments, Austin, TX USA) calculated Z(f) according to the equation 
Z(f) = U(f)/I(f).
RHE, mRHE, and RCE models were measured in a 24-well plate (Brand, Wertheim, Germany) with an 
in-house-developed measuring chamber (Supplementary Fig. 1). The insert and the well were filled with 0.5 ml 
EpiLife® basal medium (Thermo Fisher Scientific, Waltham, MA USA) to ensure contact with the electrodes. For 
each well, impedance was measured over a frequency range from 1 Hz to 100 kHz at 40 logarithmically distributed 
sampling points.
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Eye irritation test. The eye irritation test was based on the test protocol of the OECD test guideline 492 to 
ensure the high quality standards for the validation of a new test system9. In short, three independent test runs 
with two technical duplicates were performed for each model. The tissue models were measured via impedance 
spectroscopy before the eye irritation test. Models were then moisturized with 20 µl phosphate-buffered saline. 
50 µl of liquid test substances was applied in duplicates for 30 minutes, washed three times, submersed in a 12-well 
plate with 2.5 ml culture medium for 12 minutes and let to rest under normal culture conditions for 120 minutes. 
50 mg of solid test substances was applied in duplicates for 6 hours, washed three times, submersed in a 12-well 
plate with 2.5 ml culture medium for 25 minutes and let to rest under normal culture conditions for 18 hours. 
Phosphate-buffered saline was employed as negative control and 5% sodium dodecyl sulfate as positive control. 
The impedance of the models was measured again. Subsequently, a MTT-test was performed as described above 
and measured in duplicates with a spectrometer (Infinite M200 Pro, Tecan, Männedorf, Switzerland) at a wave-
length of 570 nm using isopropanol as blank.
Statistical analysis. Datasets were tested for normality with the D’Agostino-Pearson omnibus test. Based 
on normality, statistical differences were analyzed by one-way ANOVA or Kruskal-Wallis. Values of p < 0.05 were 
considered to be significant. Datasets were analyzed in GraphPad PRISM 6 (GraphPad Software Inc., La Jolla, CA 
USA).
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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